SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (DXCM) (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System ...
Dexcom Academy reflects Dexcom’s ongoing investment in both product excellence and the education that underpins effective ...
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Morgan Stanley analyst Patrick Wood upgraded the stock to Overweight from Equal Weight on Tuesday, citing a favorable ...
Partnership will enable two-way data flow between Dexcom glucose biosensors and apps and Oura Ring and the Oura App, providing a first-of-its-kind metabolic health management experience Co-marketing ...
Dexcom has kick-started a new, multiyear program that spotlights college athletes with diabetes to inspire others living with the disease to continue playing sports. Maker of continuous glucose ...
TipRanks on MSN
Citi ups DexCom target, adds 'upside 90-day catalyst watch'
Citi raised the firm’s price target on DexCom (DXCM) to $77 from $75 and keeps a Buy rating on the shares. Citi also opened an “upside 90-day catalyst watch” on DexCom. The firm sees the stock moving ...
BEDFORD, MA--(Marketwired - Aug 5, 2014) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, and DexCom, Inc (NASDAQ: DXCM ...
Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes. Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback